This indicates that our model can accurately identify IE/IT patients, but may misclassify a small proportion of atypical cases of MPN patients (referring to patient with young age, low platelet count, and low TNF levels, with small spleen) as IE/IT. This evidence concerns the gene TNF and myeloproliferative neoplasm.